{"id":1803,"date":"2023-11-08T13:44:44","date_gmt":"2023-11-08T13:44:44","guid":{"rendered":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/resultats-de-lenquete-internationale-des-patients-2022\/"},"modified":"2026-03-31T15:34:13","modified_gmt":"2026-03-31T15:34:13","slug":"2022-global-patient-survey-on-kidney-cancer-results-2","status":"publish","type":"post","link":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/2022-global-patient-survey-on-kidney-cancer-results-2\/","title":{"rendered":"R\u00e9sultats de l&rsquo;enqu\u00eate internationale des patients 2022"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text]L&rsquo;<a href=\"https:\/\/ikcc.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">International Kidney Cancer Coalition (IKCC)<\/a>, en partenariat avec les associations de patients partout dans le monde, a men\u00e9 une enqu\u00eate internationale des patients 2022. Tous les patients, les proches aidants et les survivants \u00e9taient encourag\u00e9s \u00e0 t\u00e9moigner de leur exp\u00e9rience et de leur point de vue sur le cancer du rein par le biais de cette enqu\u00eate en ligne.<\/p>\n<p>L\u2019enqu\u00eate est con\u00e7ue pour identifier les variations g\u00e9ographiques de l\u2019exp\u00e9rience des patients, de souligner les meilleures pratiques et les besoins non satisfaits li\u00e9s \u00e0 l\u2019acc\u00e8s aux soins, d\u2019\u00e9valuer la qualit\u00e9 de vie, de d\u00e9terminer la pr\u00e9valence de la prise de d\u00e9cision partag\u00e9e et d\u2019\u00e9tudier la participation aux essais cliniques. L\u2019enqu\u00eate de 2022 examina \u00e9galement la fa\u00e7on dont les patients per\u00e7oivent la surveillance active, l\u2019admissibilit\u00e9 et l\u2019acc\u00e8s aux tests g\u00e9n\u00e9tiques, ainsi que les pr\u00e9f\u00e9rences des patients en mati\u00e8re d\u2019imagerie apr\u00e8s une chirurgie du cancer du rein.<br \/>\n`<br \/>\nLes patients et les proches aidants canadiens ont obtenu l&rsquo;un des taux de participation les plus \u00e9lev\u00e9s parmi 39 pays. Gr\u00e2ce \u00e0 votre participation, un rapport canadien sur les r\u00e9sultats de l&rsquo;enqu\u00eate a \u00e9t\u00e9 produit pour informer et soutenir nos efforts de plaidoyer. Vous pouvez consulter les rapports de l&rsquo;enqu\u00eate mondiale sur les patients en cliquant sur les liens ci-dessous. <em>\u00c0 noter, les rapports sont en anglais<\/em>.<\/p>\n<p>Merci \u00e0 tous ceux qui ont particip\u00e9 \u00e0 l&rsquo;enqu\u00eate internationale des patients 2022.[\/vc_column_text][vc_empty_space][\/vc_column][\/vc_row][vc_row][vc_column width=\u00a0\u00bb1\/4&Prime;][vc_column_text]<\/p>\n<p style=\"text-align: center;\">\n<p>[\/vc_column_text][vc_empty_space][\/vc_column][vc_column width=\u00a0\u00bb1\/4&Prime;][vc_column_text]<\/p>\n<p style=\"text-align: center;\">\n<p>[\/vc_column_text][vc_empty_space][\/vc_column][vc_column width=\u00a0\u00bb1\/4&Prime;][vc_column_text]<\/p>\n<p style=\"text-align: center;\">\n<p>[\/vc_column_text][vc_empty_space][\/vc_column][vc_column width=\u00a0\u00bb1\/4&Prime;][vc_column_text]<\/p>\n<p style=\"text-align: center;\">\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text]L&rsquo;International Kidney Cancer Coalition (IKCC), en partenariat avec les associations de patients partout dans le monde, a men\u00e9 une enqu\u00eate internationale des patients 2022. Tous les patients, les proches aidants et les survivants \u00e9taient encourag\u00e9s \u00e0 t\u00e9moigner de leur exp\u00e9rience et de leur point de vue sur le cancer du rein par le biais de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1796,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[42],"year-of-the-new":[54],"class_list":["post-1803","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee","tag-evenements","year-of-the-new-54"],"_links":{"self":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/1803","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/comments?post=1803"}],"version-history":[{"count":1,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/1803\/revisions"}],"predecessor-version":[{"id":1804,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/1803\/revisions\/1804"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media\/1796"}],"wp:attachment":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media?parent=1803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/categories?post=1803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/tags?post=1803"},{"taxonomy":"year-of-the-new","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/year-of-the-new?post=1803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}